Eden Research (LON:EDEN) Shares Down 13.2% – Here’s Why

Eden Research plc (LON:EDEN)’s stock price dropped 13.2% during mid-day trading on Tuesday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares traded hands during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm has a 50-day simple moving average of GBX 3.39 and a 200 day simple moving average of GBX 3.72. The company has a market cap of £12.13 million, a price-to-earnings ratio of -7.97 and a beta of 0.92.

Insider Activity

In related news, insider Lykele van der Broek bought 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,229.97). Also, insider Alexander John Abrey purchased 167,947 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The shares were bought at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,509.57). Insiders have acquired 964,487 shares of company stock valued at $3,690,001 in the last ninety days. 14.02% of the stock is currently owned by company insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.